Order
27218-46-8
4-{2-[3-(4-chlorophenyl)-5-(trifluoromethyl)-4H-pyrazol-4-ylidene]hydrazino}morpholine
Order
2134-96-5
(6S)-5-[(E)-Ethylidene]-1,2,3,4,5,6,7,9-octahydro-6-(2-hydroxyethyl)-3-methyl-8H-azecino[5,4-b]indol-8-one
Order
27220-60-6
8-ethyl-3-(3-formamidosalicylamido)-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl isovalerate
Order
27218-48-0
N,N-dimethyl-2-{(3Z)-1-methyl-3-[3-thiophen-2-yl-5-(trifluoromethyl)-4H-pyrazol-4-ylidene]triazanyl}ethanamine
Order
338990-31-1
(2-(((1-Chloroethoxy)carbonyl)(methyl)amino)pyridin-3-yl)methyl 2-((tert-butoxycarbonyl)(methyl)amino)acetate
213488-01-8,213490-68-7,2134-96-5,2939-97-1,29401-90-9,2940-19-4 Supplier | KINGPHARM.GROUP
CMO CDMO service. KINGPHARM.GROUP supply 213488-01-8,213490-68-7,2134-96-5,2939-97-1,29401-90-9,2940-19-4 and related compounds.
2134-96-5
2940-19-4
29401-90-9
213490-68-7
2939-97-1
213488-01-8